Literature DB >> 10837580

In vitro cell models to study nasal mucosal permeability and metabolism.

.   

Abstract

Whereas in vivo studies represent the most crucial test for any nasal drug application or formulation, mechanistic aspects of nasal absorption may be more clearly approached by well defined and controlled in vitro studies. In this review the progress of nasal in vitro models to investigate drug permeation and metabolism in the epithelium is summarized and their potential and limitations are discussed. The following subjects will be covered: (i) primary cell cultures of human nasal epithelium, including sampling techniques and culture conditions, (ii) human nasal cell lines (in particular the human nasal cell line RPMI 2650), and (iii) excised nasal epithelium (rabbit, bovine, ovine, canine, human), also summarizing suitable preparation techniques and tissue characterization, test media, tissue equilibration, viability testing, and integrity tests. Furthermore, an overview on the various experimental set-ups suitable for in vitro transport studies (permeation rates; identification of permeation pathways; mechanisms and toxicity of absorption enhancers) and for metabolism studies (rates, saturation and pathways of enzymatic cleavage) is presented. Some attention is given to identify potential endocytotic uptake mechanisms. To date, the permeation and metabolic barrier function of excised nasal tissue derived from various animals has shown to mimic the in vivo situation 'ex vivo' at the highest degree possible. Supply of human tissue will continue to be short. Therefore, further studies are necessary to evaluate and improve culture conditions, handling, performance and physiologic relevance of primary human cell and cell line cultures.

Entities:  

Year:  1998        PMID: 10837580     DOI: 10.1016/s0169-409x(97)00061-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  21 in total

1.  Nasal epithelial permeation of thymotrinan (TP3) versus thymocartin (TP4): competitive metabolism and self-enhancement.

Authors:  M C Schmidt; W Rubas; H P Merkle
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

Review 2.  Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells.

Authors:  Bruno Guy
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

Review 3.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 4.  Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Authors:  Clément Mercier; Nathalie Perek; Xavier Delavenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

5.  Retinoic acid and hydrocortisone strengthen the barrier function of human RPMI 2650 cells, a model for nasal epithelial permeability.

Authors:  Levente Kürti; Szilvia Veszelka; Alexandra Bocsik; Béla Ozsvári; László G Puskás; Agnes Kittel; Piroska Szabó-Révész; Mária A Deli
Journal:  Cytotechnology       Date:  2012-09-02       Impact factor: 2.058

6.  Correlation between nasal membrane permeability and nasal absorption rate.

Authors:  Hefei Zhang; Chih-Wei Lin; Maureen D Donovan
Journal:  AAPS PharmSciTech       Date:  2012-12-07       Impact factor: 3.246

7.  The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.

Authors:  Mateja Erdani Kreft; Urška Dragin Jerman; Eva Lasič; Tea Lanišnik Rižner; Neli Hevir-Kene; Luka Peternel; Katja Kristan
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

8.  [In vitro exposure of human nasal mucous membrane cells and lymphocytes to snuff].

Authors:  S Bunk; L Übelacker; A Scherzad; J Hochstöger; N Poier; S Hackenberg; N Kleinsasser
Journal:  HNO       Date:  2020-01       Impact factor: 1.284

9.  The Bps polysaccharide of Bordetella pertussis promotes colonization and biofilm formation in the nose by functioning as an adhesin.

Authors:  Matt S Conover; Gina Parise Sloan; Cheraton F Love; Neelima Sukumar; Rajendar Deora
Journal:  Mol Microbiol       Date:  2010-07-30       Impact factor: 3.501

10.  Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.

Authors:  Jin-Wook Yoo; You-Sun Kim; Sun-Hee Lee; Min-Ki Lee; Hwan-Jung Roh; Byung-Hak Jhun; Chi-Ho Lee; Dae-Duk Kim
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.